Price
No data yet.
Social Signal Score
Analyst Ratings
19 analystsRevenue
$50.22M+2153.15%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Jerrell W. Shelton
- Sector
- Industrials
- Industry
- Integrated Freight & Logistics
- Employees
- 688
- Beta
- 1.89
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- 1.39
Financials
Revenue
$50.22M+2153.2%Net Income
$-10.85MEBITDA
$-3.67MFree Cash Flow
$-40.0KEPS (diluted)
$-0.25Shares Outstanding (diluted)
50.65M+187.7%Operating Expenses
$32.64MCash & Debt
$393.08MReturn of Capital
$6.00MRevenue by Segment (annual)
$176.18MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $176.18M | $78.30M | $1.40 |
| 2024 | $233.25M | $-99.59M | $-2.21 |
| 2023 | $237.28M | $-37.33M | $-0.93 |
| 2022 | $222.61M | $-275.53M | $-6.18 |
| 2021 | $222.61M | $-275.53M | $-6.18 |
| 2020 | $78.70M | $-32.69M | $-1.94 |
| 2019 | $33.94M | $-18.33M | $-0.55 |
| 2018 | $19.63M | $-9.56M | $-0.34 |
| 2017 | $11.95M | $-7.90M | $-0.34 |
| 2016 | $7.68M | $-13.11M | $-0.92 |
| 2015 | $5.88M | $-9.82M | $-1.34 |
| 2014 | $3.94M | $-7.03M | $-2.27 |
| 2013 | $2.66M | $-19.57M | $-4.48 |
| 2012 | $1.10M | $-6.38M | $-1.89 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $2.30
- Implied price
- $16.08
- Return from $19.69
- -4.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $8.00 — -59.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 3 | 5 | 7 | 9 | 11 |
|---|---|---|---|---|---|
| -2.0% | -26.4% | -18.5% | -12.9% | -8.4% | -4.6% |
| 3.0% | -22.7% | -14.4% | -8.4% | -3.7% | 0.3% |
| 8.0% | -18.9% | -10.2% | -4.0% | 1.0% | 5.1% |
| 13.0% | -15.2% | -6.1% | 0.5% | 5.7% | 10.0% |
| 18.0% | -11.4% | -1.9% | 4.9% | 10.3% | 14.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
160+128.57%Social Signal Score
Mentions (8)
- Newsseekingalpha.com·16d ago·Positive
Cryoport, Inc. (CYRX) Q3 2026 Earnings Call Transcript Cryoport, Inc. ( CYRX ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Jerrell Shelton - Chairman, President & CEO Robert Stefanovich - Senior VP, CFO, Treasurer & Chief Administrative Officer Thomas Heinzen - Vice President of Corporate Development & Investor Relations Mark W. Sawicki - Senior VP & Chief Scientific Officer Conference Call Participants Todd Fromer - Kanan, Corbin, Schupak & Aronow, Inc. Philip Seungh…
View source ↗ - Newsmarketbeat.com·16d ago·Neutral
CryoPort Q3 Earnings Call Highlights CryoPort NASDAQ: CYRX raised its full-year 2026 revenue outlook after reporting third-quarter revenue growth of 14%, supported by demand for its cell and gene therapy services and cryogenic products.
View source ↗ - Newszacks.com·17d ago·Negative
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.18 per share a year ago.
View source ↗ - Newsprnewswire.com·17d ago·Neutral
…as of September 30, 2026 Raises full-year 2026 revenue guidance to $197 million - $199 million NASHVILLE, Tenn., Nov. 5, 2026 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced financial results for its third quarter (Q3) and first nine months (9M) of 2026.
View source ↗ - Newsprnewswire.com·31d ago·Neutral
Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026 NASHVILLE, Tenn., Oct. 22, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, today announced that the Company will report financial results for the third quarter ended September 30, 2026 on Thursday, November 5, 2026 after U.S. markets close.
View source ↗ - Newszacks.com·52d ago·Positive
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year? Here is how CryoPort, Inc. (CYRX) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
View source ↗ - Newsseekingalpha.com·58d ago·Positive
Cryoport: Strong Pipeline Of Cell And Gene Therapy Approvals Cryoport, Inc., rated BUY, is up 82% YTD, driven by robust cell and gene therapy (CGT) commercialization and pipeline momentum. CYRX returned to adjusted EBITDA profitability in 2Q26, with strong Life Science Services growth and positive operating cash flow of $8 million TTM. Management expects 5 new CGT commercial approvals in 2026, supported by a 15% YoY increase in the Phase 3 trial pipeline to 94 trials.
View source ↗ - Newszacks.com·103d ago·Positive
CryoPort (CYRX) Upgraded to Buy: Here's Why CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗
Earnings
Tue, Mar 2(in 3 months)
Consensus estimate $-0.18 per share
Typical surprise -10.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Nov 5$-0.25 vs $-0.18miss
- Thu, Aug 6$-0.20 vs $-0.19miss
- Mon, May 4$-0.23 vs $-0.20miss
- Tue, Mar 3$-0.21 vs $-0.19miss
- Tue, Nov 4$-0.18 vs $-0.23beat
- Tue, Aug 5$-0.29 vs $-0.20miss
Estimates and results for CYRX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CYRX officers and directors.
- Bought
- —
- Sold
- $10.0m
0 trades
30 trades
- Sawicki Mark Wsold
- Hancock Daniel Msold
- Shelton Jerrellsold
- Zecchini Edward Jsold
- Zecchini Edward Jsold
- Mandalam Ramkumarsold
- Stefanovich Robertsold
- Stefanovich Robertsold
70 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Josh Gottheimerhouse · NJ05 · disclosed Oct 15, 2023 (30d later)Sell$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Mar 3, 2022 (3d later)Sell$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Feb 1, 2022 (19d later)Sell$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Feb 1, 2022 (1d later)Sell$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Feb 1, 2022 (18d later)Sell$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Oct 1, 2021 (10d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Dec 15, 2020 (21d later)Sell$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed Dec 9, 2020 (26d later)Sell$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Dec 1, 2020 (14d later)Buy$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Dec 1, 2020 (29d later)Buy$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Aug 9, 2020 (26d later)Sell$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed May 31, 2020 (24d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Mar 10, 2020 (33d later)Buy$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Feb 22, 2020 (40d later)Buy$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Feb 22, 2020 (4d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Feb 18, 2020 (32d later)Buy$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed Feb 10, 2020 (27d later)Buy$1,001 - $15,000
- Donald Sternoff Beyerhouse · VA08 · disclosed Jan 2, 2020 (10d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
